Nobel-winning UK scientist launches programme to develop hepatitis C vaccine in Hong Kong
GlobeAlert Desk · curated from South China Morning Post · East Asia
A British Nobel-winning virologist has launched a programme to develop the world’s first hepatitis C vaccine after joining a university in Hong Kong, tapping the city’s research funding, access to Chinese strains of the virus and partnerships with mainland drug-makers. Sir Michael Houghton, who won the 2020 Nobel Prize in Physiology or Medicine for the co-discovery of the hepatitis C virus, said he joined Baptist University after more than four decades in North America, as the United States and...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
What the desk knows about this story
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Single-source so far. Treat details as unconfirmed until more publishers report.
Not flagged as developing.
- The coral reef is too crowded shots prohibited between divers at 18 meters depth he tried to take my snorkel awayShootings · China · 6h ago
- Japan pm vows breakthrough on n. korea abduction issueKidnappings · North Korea · 1d ago
- Long March 12 | SatNet LEO Group TBD?Rocket Launches · CHN · now